When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Fate Therapeutics Stock Forecast


$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Hollow Logo Score: 5.137

Fate Therapeutics Stock Forecast

$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Score Hollow Logo 5.137

FATE Price Targets and Analyst Ratings NASDAQ:FATE

FATE Forecast. What You Should Know.

FATE Historical Ratings and Targets

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... Read more


StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE